Advanced leukemias
Showing 1 - 25 of >10,000
Leukemias, MDS Trial in Houston (sapacitabine)
Completed
- Leukemias
- Myelodysplastic Syndromes
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Dec 7, 2021
Liver Cancer, Pancreatic Cancer, Brain Tumor Trial in Beijing (anti-CD133-CAR vector-transduced T cells)
Completed
- Liver Cancer
- +6 more
- anti-CD133-CAR vector-transduced T cells
-
Beijing, Beijing, ChinaBiotherapeutic Department and Pediatrics Department of Chinese P
Dec 15, 2019
Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)
Recruiting
- Neoplasms
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Tumors, Solid Tumors Trial run by the NCI (TdCyd)
Suspended
- Neoplasms
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 6, 2022
Leukemia Trial in Houston (MEK 162)
Terminated
- Leukemia
- MEK 162
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 25, 2021
Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded
Not yet recruiting
- Refractory Leukemia
- +4 more
- STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
- Dendritic Cell Vaccine
-
Miami, FloridaUniversity of Miami
Jan 23, 2023
Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati
Recruiting
- Relapsed/Refractory Leukemias
- +4 more
- SNDX-5613
- +2 more
-
Kansas City, Missouri
- +1 more
Jul 18, 2022
B Cell Acute Lymphoblastic Leukemia (B-ALL), B Lineage Lymphoblastic Lymphoma Trial (Autologous Humanized CD19-Directed Chimeric
Not yet recruiting
- B Cell Acute Lymphoblastic Leukemia (B-ALL)
- B Lineage Lymphoblastic Lymphoma
- Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)
- (no location specified)
Jul 27, 2022
Esophageal Cancer Trial in Saint Louis
Completed
- Esophageal Cancer
-
Saint Louis, MissouriWashington University School of Medicine
Aug 8, 2022
Development of B-cell Leukemias and Lymphomas in Children of
Not yet recruiting
- B Cell Leukemia
- Lymphoma
- SNP analysis of the DNA
- (no location specified)
Oct 26, 2021
Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate
Recruiting
- Non Malignant Diseases
- +2 more
- RIC: Distal Campath
- +2 more
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 8, 2022
The Pediatric Acute Leukemia Screening Trial - A Study to Test
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +7 more
- Biospecimen Collection
-
Birmingham, Alabama
- +144 more
Jan 30, 2023
Tumors Trial in San Jose del Cabo, Torreon (Anti-Bacterial Agents, Anti-Fungal Agents, Anti-Protozoal Agents)
Recruiting
- Neoplasms
- Anti-Bacterial Agents
- +2 more
-
San Jose del Cabo, Baja California Sur, Mexico
- +1 more
Mar 26, 2022
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in
Not yet recruiting
- Acute Myeloid Leukemia
- Genetic Predisposition to Disease
- Collection of blood sample of bone marrow (cohort 1)
- Collection of blood sample of bone marrow (cohort 2 and 3)
- (no location specified)
Mar 6, 2023
Patients With Acute Leukemia Infected by COVID-19
Completed
- Acute Myeloblastic Leukemia
- +2 more
-
Amiens, France
- +26 more
Jul 26, 2022
PET-CT Imaging in Relapsed/Refractory Acute Leukemias
Not yet recruiting
- B Cell
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 4, 2023
Tumor, Stomach, Gastric Tumors Malignant, Pancreatic Tumors Trial in Bogotá (Petiveria Alliacea Preparation, Placebo)
Not yet recruiting
- Neoplasm, Stomach
- +8 more
- Petiveria Alliacea Preparation
- Placebo
-
Bogotá, ColombiaPontificia Universidad Javeriana
Oct 16, 2022